About genomic testing and insurance discrimination:

Use of genetic information by life insurance companies has been frequently described as a barrier to uptake of genetic testing and participation in genetics research.

In Australia, there is no government oversight of the use of genomic information in life insurance underwriting. In 2019, the life insurance industry body, the Financial Services Council, introduced a self-regulated agreement to restrict life insurers’ use of genetic testing for certain policy limits.

About the A-Glimmer study:

The study aimed to understand the impact, effectiveness and appropriateness of the Australian life insurance moratorium, taking into account four different stakeholder perspectives:

• Genetic healthcare professionals

• Patients and consumers

• Insurance industry

• Genetics researchers

To find out more visit the A Glimmer Website.

Contact us: aglimmer.study@monash.edu